期刊
MOLECULAR & CELLULAR ONCOLOGY
卷 6, 期 5, 页码 -出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/23723556.2019.1627273
关键词
N-acetyl-aspartyl-glutamate (NAAG); glutamate carboxypeptidase II (GCPII); glutaminase inhibitor; glutamate reservoir; stable isotope-resolved metabolomics (SIRM)
类别
资金
- NIH [R01-CA193895, R01-CA 112314, 1S10OD025226-01, UL1 TR 001079]
- Allegheny Health Network-Johns Hopkins Cancer Research Fund
- Doris M. Weinstein Pancreatic Cancer Research Fund
We uncovered the neurotransmitter N-acetyl-aspartyl-glutamate (NAAG) as a reservoir providing glutamate to promote cancer growth, and demonstrated that inhibition of NAAG hydrolysis by targeting glutamate carboxypeptidase II is a viable strategy for cancer therapy. Our study also suggests that NAAG concentration in plasma could be a non-invasive measurement to monitor cancer progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据